NUCLEOCAPTURE Trademark

Trademark Overview


On Tuesday, September 7, 2021, a trademark application was filed for NUCLEOCAPTURE with the United States Patent and Trademark Office. The USPTO has given the NUCLEOCAPTURE trademark a serial number of 97015169. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, March 15, 2024. This trademark is owned by Santersus AG. The NUCLEOCAPTURE trademark is filed in the Medical Instrument Products category with the following description:

Surgical, medical, and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; resuscitation apparatus; dialyzers; medical apparatus and instruments, namely, apparatus for extracorporeal treatment of body fluids, namely for extracorporeal removal of Neutrophil extracellular traps ("NETs") and cell-free Deoxyribonucleic acid ("cfDNA") from blood; medical devices, namely, absorption devices and absorption materials sold as a unit for removing substances and materials from biological and any other biocompatible fluids, namely, cerebrospinal fluid, blood, blood fractions
nucleocapture

General Information


Serial Number97015169
Word MarkNUCLEOCAPTURE
Filing DateTuesday, September 7, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, March 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Goods and ServicesSurgical, medical, and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; resuscitation apparatus; dialyzers; medical apparatus and instruments, namely, apparatus for extracorporeal treatment of body fluids, namely for extracorporeal removal of Neutrophil extracellular traps ("NETs") and cell-free Deoxyribonucleic acid ("cfDNA") from blood; medical devices, namely, absorption devices and absorption materials sold as a unit for removing substances and materials from biological and any other biocompatible fluids, namely, cerebrospinal fluid, blood, blood fractions

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, October 18, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSantersus AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKüsnacht 8127
CH

Party NameSantersus AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKüsnacht 8127
CH

Trademark Events


Event DateEvent Description
Saturday, March 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2024SOU EXTENSION 1 GRANTED
Friday, March 15, 2024SOU EXTENSION 1 FILED
Friday, March 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 4, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 9, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 9, 2022FINAL REFUSAL E-MAILED
Wednesday, November 9, 2022FINAL REFUSAL WRITTEN
Thursday, October 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 13, 2022NON-FINAL ACTION E-MAILED
Monday, June 13, 2022NON-FINAL ACTION WRITTEN
Friday, June 10, 2022ASSIGNED TO EXAMINER
Monday, October 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 10, 2021NEW APPLICATION ENTERED